Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

JumpstartMD vs MDLive

JumpstartMD
Graded #440

Lower grade

vs+3.3999999999999986
MDLive
Graded #357

Higher grade

The verdict

MDLive takes it — 58.8/100 to 55.4/100.

MDLive grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MDLive (an Evernorth/Cigna company) is a large telehealth provider offering urgent care, primary care, dermatology and behavioral health.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationMDLive +13
40
53
Clinical oversightMDLive +5
80
85
Labs & monitoringMDLive +1
53
54
FulfillmentJumpstartMD +3
65
62
Contract termsEven
55
55
JumpstartMD · left barMDLive · right bar

The numbers

MetricJumpstartMDMDLive
WeighScore55.4/10058.8/100
GradeCC
Scorecard rank#440#357
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
Coverage1 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
JumpstartMD

Graded #440 · C

Strengths

  • Both semaglutide and tirzepatide available

Where it loses points

  • Pricing not publicly disclosed
MDLive

Graded #357 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s including Wegovy and Zepbound
  • Covered through insurance and employer benefits for 50M-plus people
  • Board-certified physicians averaging about 15 years of experience
  • Part of Evernorth/Cigna, a large established healthcare organization
  • Offers full primary care, not just a single weight-loss funnel

Where it loses points

  • GLP-1s only at clinician discretion in a Primary Care routine visit
  • Anti-obesity meds not available in FL, LA, MS or NJ
  • Distributed mainly via insurers and employers; cost varies by plan
  • No transparent published monthly cash price for GLP-1 care

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard